Português

Inglês

Home | Site Map | Add to Favorites Link | Send page to a Friend | Contact us

All Content

Revistas e artigos de divulgação

E-DRUG - September 2010

News from Brazil: a new drug candidate and a new approach to fighting infectious diseases

SCIENCE IN AFRICA : November 2010

Brazilian and American scientists have demonstrated that a compound known as P-Mapa is active against Mycobacterium tuberculosis in vivo.

Brazilian drug shows potential against tuberculosis and cancer- August 2012

In an article recently published in Infectious Agents and Cancer, Brazilian and North American researchers showed that a drug developed in Brazil, called P-MAPA, is able to activate certain immune system receptors and helps fight tuberculosis and bladder cancer.

Brazilian drug improves the immunity of dogs with leishmaniasis

A study published recently in the journal Acta Tropica has shown that P-MAPA, a drug developed in Brazil has shown effectiveness in improving the clinical state and immunity of dogs with symptoms of leishmaniasis

Sala de imprensa

Brazil-based research network announces the effectiveness of a new antiviral

Farmabrasilis announces the publication of the effectiveness of P-MAPA, a new immunomodulator, for antiviral applications, in the journal Antiviral Research. This research was conducted in collaboration with Dr. Brian Gowen at the Institute for Antiviral Research of Utah State University and was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

A novel immunotherapy to fight bladder cancer

Collaborating to move new treatments forward: Scientific rationale for the use of P-MAPA immunotherapy in the treatment of bladder cancer

Relatórios Clínicos

Clinical Trial - Phase I

Objectives: Primary: To determine the toxicity and side effects, of P-MAPA immunomodulator in HIV + individuals. Secondary: To determine the local and systemic effect, if any, of P-MAPA in the individuals.To determine the effect, if any, in the white blood cell count.

Projetos de utilização clínica

The Farmabrasilis Infectious Diseases Proposal :

A new, powerful, affordable immunomodulator and a strategy for large-scale deployment

P-MAPA against visceral leishmaniasis: An One Health approach

Exploring an one health approach for treatment of leishmaniasis

A novel immunotherapy to fight bladder cancer

Collaborating to move new treatments forward: Scientific rationale for the use of P-MAPA immunotherapy in the treatment of bladder cancer

[ First ] [ Previous ] [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] [ Next ] [ Last ]

Lógica Digital

Privacy Policy | Legal | [email protected] all rights reserved